Please enable JavaScript to continue using this application.

Compare $ALEC vs $STRO | Chartloom

Compare

$ALEC vs $STRO

Alector Inc · Sutro Biopharma Inc

ALEC

Alector Inc

STRO

Sutro Biopharma Inc

Compare $ALEC vs $STRO

Comparing Alector Inc and Sutro Biopharma Inc

ALECAlector Inc

STROSutro Biopharma Inc

ALECAlector Inc

Market cap

$231M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

34.29x

Rev growth (TTM)

-82.9%

YTD performance

35.9%

52W performance

-32.5%

FCF yield

-68.6%

STROSutro Biopharma Inc

Market cap

$236M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.01x

Rev growth (TTM)

-56.3%

YTD performance

30.2%

52W performance

67.2%

FCF yield

-61.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALEC

STRO

Detailed metrics comparison

ALEC

Alector Inc

STRO

Sutro Biopharma Inc

Market Cap

ALEC$231M

STRO$236M

Enterprise Value

ALEC$181M

STRO$421M

Price

ALEC$2.08

STRO$14.27

P/E Ratio

ALECN/A

STRON/A

P/S Ratio

ALEC16.66x

STRO5.17x

EV/Sales

ALEC13.05x

STRO9.22x

EV/EBITDA

ALEC3.60x

STRO0.00x

P/B Ratio

ALEC19.47x

STRO5.78x

P/FCF Ratio

ALECN/A

STRON/A

EV/FCF

ALEC-1.14x

STRO-2.89x

PEG Ratio

ALECN/A

STRON/A

Forward P/E (NTM)

ALECN/A

STRON/A

Forward P/S (NTM)

ALEC34.29x

STRO6.01x

Revenue (TTM)

ALEC$14M

STRO$46M

Revenue Growth (YoY)

ALEC-82.9%

STRO-56.3%

Forward Rev Growth

ALEC281.0%

STRO-19.2%

Gross Margin (TTM)

ALEC0.0%

STRO0.0%

Operating Margin (TTM)

ALEC0.0%

STRO0.0%

EBITDA Margin (TTM)

ALEC-879.7%

STRO-275.3%

Net Margin (TTM)

ALEC-850.1%

STRO-395.2%

FCF Margin (TTM)

ALEC-1142.6%

STRO-318.6%

Net Income (TTM)

ALEC$-118M

STRO$-181M

FCF (TTM)

ALEC$-158M

STRO$-146M

EPS (TTM)

ALEC-$1.06

STRO-$10.90

ROE (TTM)

ALEC-29517.0%

STRO-22384.0%

ROA (TTM)

ALEC-4400.0%

STRO-8812.0%

ROIC (TTM)

ALEC-24053.0%

STRO-22384.0%

Cash

ALEC$60M

STRO$54M

Debt

ALEC$10M

STRO$239M

Net Cash/Debt

ALEC$50M

STRO$-185M

Current Ratio (TTM)

ALEC5.26x

STRO3.32x

Quick Ratio (TTM)

ALEC5.05x

STRO3.22x

Debt/Equity (TTM)

ALEC0.94x

STRO4.05x

Debt/Assets (TTM)

ALEC0.0%

STRO0.0%

Interest Coverage (TTM)

ALECN/A

STRON/A

Net Debt/EBITDA (TTM)

ALEC0.00x

STRO0.00x

Beta

ALEC0.65

STRO1.47

52W Performance

ALEC-32.5%

STRO67.2%

YTD Performance

ALEC35.9%

STRO30.2%

% from 52W High

ALEC-38.8%

STRO-67.5%

% from 52W Low

ALEC90.8%

STRO99.6%

Asset Turnover (TTM)

ALEC0.05x

STRO0.22x

FCF Yield (TTM)

ALEC-68.6%

STRO-61.6%

Earnings Yield (TTM)

ALEC-51.0%

STRO-76.4%

Dividend Yield (TTM)

ALECN/A

STRON/A

Rule of 40

ALEC-1,225.5

STRO-374.9

EV/GP/RG

ALECN/A

STRON/A

Ticker research

View ALEC research View STRO research

Metric	ALEC Alector Inc	STRO Sutro Biopharma Inc
Market & Valuation
Market Cap	$231M	$236M
Enterprise Value	$181M	$421M
Price	$2.08	$14.27
P/E Ratio	N/A	N/A
P/S Ratio	16.66x	5.17x
EV/Sales	13.05x	9.22x
EV/EBITDA	3.60x	0.00x
P/B Ratio	19.47x	5.78x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.14x	-2.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	34.29x	6.01x
Revenue & Growth
Revenue (TTM)	$14M	$46M
Revenue Growth (YoY)	-82.9%	-56.3%
Forward Rev Growth	281.0%	-19.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-879.7%	-275.3%
Net Margin (TTM)	-850.1%	-395.2%
FCF Margin (TTM)	-1142.6%	-318.6%
Net Income (TTM)	$-118M	$-181M
FCF (TTM)	$-158M	$-146M
EPS (TTM)	-$1.06	-$10.90
ROE (TTM)	-29517.0%	-22384.0%
ROA (TTM)	-4400.0%	-8812.0%
ROIC (TTM)	-24053.0%	-22384.0%
Financial Health
Cash	$60M	$54M
Debt	$10M	$239M
Net Cash/Debt	$50M	$-185M
Current Ratio (TTM)	5.26x	3.32x
Quick Ratio (TTM)	5.05x	3.22x
Debt/Equity (TTM)	0.94x	4.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.65	1.47
52W Performance	-32.5%	67.2%
YTD Performance	35.9%	30.2%
% from 52W High	-38.8%	-67.5%
% from 52W Low	90.8%	99.6%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	0.22x
FCF Yield (TTM)	-68.6%	-61.6%
Earnings Yield (TTM)	-51.0%	-76.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,225.5	-374.9
EV/GP/RG	N/A	N/A
Ticker research	View ALEC research	View STRO research

Valuation

P/S Ratio

STRO

5.17x

ALEC

16.66x

EV/FCF

STRO

-2.89x

ALEC

-1.14x

Growth & revenue

Revenue Growth TTM

STRO

-56.3%

ALEC

-82.9%

Forward Revenue Growth

ALEC

281.0%

STRO

-19.2%

Profitability & performance

Gross Margin

ALEC

0.0%

STRO

0.0%

ROE

STRO

-22384.0%

ALEC

-29517.0%

FCF Yield %

STRO

-61.6%

ALEC

-68.6%

52-Week Performance

STRO

67.2%

ALEC

-32.5%

Detailed metrics comparison

ALEC

Alector Inc

STRO

Sutro Biopharma Inc

Market Cap

ALEC$231M

STRO$236M

Enterprise Value

ALEC$181M

STRO$421M

Price

ALEC$2.08

STRO$14.27

P/E Ratio

ALECN/A

STRON/A

P/S Ratio

ALEC16.66x

STRO5.17x

EV/Sales

ALEC13.05x

STRO9.22x

EV/EBITDA

ALEC3.60x

STRO0.00x

P/B Ratio

ALEC19.47x

STRO5.78x

P/FCF Ratio

ALECN/A

STRON/A

EV/FCF

ALEC-1.14x

STRO-2.89x

PEG Ratio

ALECN/A

STRON/A

Forward P/E (NTM)

ALECN/A

STRON/A

Forward P/S (NTM)

ALEC34.29x

STRO6.01x

Revenue (TTM)

ALEC$14M

STRO$46M

Revenue Growth (YoY)

ALEC-82.9%

STRO-56.3%

Forward Rev Growth

ALEC281.0%

STRO-19.2%

Gross Margin (TTM)

ALEC0.0%

STRO0.0%

Operating Margin (TTM)

ALEC0.0%

STRO0.0%

EBITDA Margin (TTM)

ALEC-879.7%

STRO-275.3%

Net Margin (TTM)

ALEC-850.1%

STRO-395.2%

FCF Margin (TTM)

ALEC-1142.6%

STRO-318.6%

Net Income (TTM)

ALEC$-118M

STRO$-181M

FCF (TTM)

ALEC$-158M

STRO$-146M

EPS (TTM)

ALEC-$1.06

STRO-$10.90

ROE (TTM)

ALEC-29517.0%

STRO-22384.0%

ROA (TTM)

ALEC-4400.0%

STRO-8812.0%

ROIC (TTM)

ALEC-24053.0%

STRO-22384.0%

Cash

ALEC$60M

STRO$54M

Debt

ALEC$10M

STRO$239M

Net Cash/Debt

ALEC$50M

STRO$-185M

Current Ratio (TTM)

ALEC5.26x

STRO3.32x

Quick Ratio (TTM)

ALEC5.05x

STRO3.22x

Debt/Equity (TTM)

ALEC0.94x

STRO4.05x

Debt/Assets (TTM)

ALEC0.0%

STRO0.0%

Interest Coverage (TTM)

ALECN/A

STRON/A

Net Debt/EBITDA (TTM)

ALEC0.00x

STRO0.00x

Beta

ALEC0.65

STRO1.47

52W Performance

ALEC-32.5%

STRO67.2%

YTD Performance

ALEC35.9%

STRO30.2%

% from 52W High

ALEC-38.8%

STRO-67.5%

% from 52W Low

ALEC90.8%

STRO99.6%

Asset Turnover (TTM)

ALEC0.05x

STRO0.22x

FCF Yield (TTM)

ALEC-68.6%

STRO-61.6%

Earnings Yield (TTM)

ALEC-51.0%

STRO-76.4%

Dividend Yield (TTM)

ALECN/A

STRON/A

Rule of 40

ALEC-1,225.5

STRO-374.9

EV/GP/RG

ALECN/A

STRON/A

Ticker research

View ALEC research View STRO research

Metric	ALEC Alector Inc	STRO Sutro Biopharma Inc
Market & Valuation
Market Cap	$231M	$236M
Enterprise Value	$181M	$421M
Price	$2.08	$14.27
P/E Ratio	N/A	N/A
P/S Ratio	16.66x	5.17x
EV/Sales	13.05x	9.22x
EV/EBITDA	3.60x	0.00x
P/B Ratio	19.47x	5.78x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.14x	-2.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	34.29x	6.01x
Revenue & Growth
Revenue (TTM)	$14M	$46M
Revenue Growth (YoY)	-82.9%	-56.3%
Forward Rev Growth	281.0%	-19.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-879.7%	-275.3%
Net Margin (TTM)	-850.1%	-395.2%
FCF Margin (TTM)	-1142.6%	-318.6%
Net Income (TTM)	$-118M	$-181M
FCF (TTM)	$-158M	$-146M
EPS (TTM)	-$1.06	-$10.90
ROE (TTM)	-29517.0%	-22384.0%
ROA (TTM)	-4400.0%	-8812.0%
ROIC (TTM)	-24053.0%	-22384.0%
Financial Health
Cash	$60M	$54M
Debt	$10M	$239M
Net Cash/Debt	$50M	$-185M
Current Ratio (TTM)	5.26x	3.32x
Quick Ratio (TTM)	5.05x	3.22x
Debt/Equity (TTM)	0.94x	4.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.65	1.47
52W Performance	-32.5%	67.2%
YTD Performance	35.9%	30.2%
% from 52W High	-38.8%	-67.5%
% from 52W Low	90.8%	99.6%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	0.22x
FCF Yield (TTM)	-68.6%	-61.6%
Earnings Yield (TTM)	-51.0%	-76.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,225.5	-374.9
EV/GP/RG	N/A	N/A
Ticker research	View ALEC research	View STRO research